Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Douglas, Nace"'
Autor:
Eric Rogier, Nastassia Battle, Catherine Bakari, Misago D. Seth, Douglas Nace, Camelia Herman, Achut Barakoti, Rashid A. Madebe, Celine I. Mandara, Beatus M. Lyimo, David J. Giesbrecht, Zachary R. Popkin-Hall, Filbert Francis, Daniel Mbwambo, Issa Garimo, Sijenunu Aaron, Abdallah Lusasi, Fabrizio Molteni, Ritha Njau, Jane A. Cunningham, Samwel Lazaro, Ally Mohamed, Jonathan J. Juliano, Jeffrey A. Bailey, Venkatachalam Udhayakumar, Deus S. Ishengoma
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Plasmodium falciparum with the histidine rich protein 2 gene (pfhrp2) deleted from its genome can escape diagnosis by HRP2-based rapid diagnostic tests (HRP2-RDTs). The World Health Organization (WHO) recommends switching to a non-HRP2 RDT f
Externí odkaz:
https://doaj.org/article/d92f31d7cdc04d58bd7d693c2fc892ca
Autor:
Eric Rogier, Catherine Bakari, Celine I. Mandara, Mercy G. Chiduo, Mateusz Plucinski, Douglas Nace, Nastassia Battle, Franky Chacky, Susan F. Rumisha, Fabrizio Molteni, Renata Mandike, Sigsbert Mkude, Ritha Njau, Ally Mohamed, Venkatachalam Udhayakumar, Deus S. Ishengoma
Publikováno v:
Malaria Journal, Vol 21, Iss 1, Pp 1-10 (2022)
Abstract Background Malaria rapid diagnostic tests (RDTs) based on the detection of the Plasmodium falciparum histidine-rich protein 2 (HRP2) antigen are widely used for detection of active infection with this parasite and are the only practical mala
Externí odkaz:
https://doaj.org/article/10fbc7597b22413d84f5d0f1634faaeb
Autor:
Jessica N. McCaffery, Douglas Nace, Camelia Herman, Balwan Singh, Eric Mukomena Sompwe, Papy Mandoko Nkoli, Dieudonné Mumba Ngoyi, Gauthier Mesia Kahunu, Eric S. Halsey, Eric Rogier
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Rapid diagnostic tests (RDTs) detecting histidine-rich protein 2 (HRP2) and HRP3 are widely used throughout sub-Saharan Africa (SSA) to diagnose Plasmodium falciparum malaria. However, multiple SSA countries have reported pfhrp2 and pfhrp3 (
Externí odkaz:
https://doaj.org/article/03ffc4d8850543d28ee7154f6741d18d
Autor:
Kaitlin F. Mitchell, Christina M. Carlson, Douglas Nace, Brian S. Wakeman, Jan Drobeniuc, Glenn P. Niemeyer, Bonnie Werner, Alex R. Hoffmaster, Panayampalli S. Satheshkumar, Amy J. Schuh, Venkatachalam Udhayakumar, Eric Rogier
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 3 (2022)
ABSTRACT Serological assays for SARS-CoV-2 antibodies must be validated for performance with a large panel of clinical specimens. Most existing assays utilize a single antigen target and may be subject to reduced diagnostic specificity. This study ev
Externí odkaz:
https://doaj.org/article/3fe0d9430c0e4ea8a57507d465ba0f68
Autor:
Youssouf Diarra, Oumar Koné, Lansana Sangaré, Lassina Doumbia, Dade Bouye Ben Haidara, Mouctar Diallo, Ababacar Maiga, Hamadoun A. Sango, Halidou Sidibé, Jules Mihigo, Douglas Nace, Dragan Ljolje, Eldin Talundzic, Venkatachalam Udhayakumar, Erin Eckert, Celia J. Woodfill, Leah F. Moriarty, Pharath Lim, Donald J. Krogstad, Eric S. Halsey, Naomi W. Lucchi, Ousmane A. Koita
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-13 (2021)
Abstract Background The current first-line treatments for uncomplicated malaria recommended by the National Malaria Control Programme in Mali are artemether–lumefantrine (AL) and artesunate–amodiaquine (ASAQ). From 2015 to 2016, an in vivo study
Externí odkaz:
https://doaj.org/article/ce50d1a8576342ba839a66fb31f52bfd
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-7 (2021)
Abstract Background The Plasmodium falciparum antigen histidine rich protein 2 (HRP2) is a preferred target for malaria rapid diagnostic tests (RDTs) because of its abundant production by the parasite and thermal stability. As a result, a majority of
Externí odkaz:
https://doaj.org/article/ea31bd079afc4278b1cd1d68d0d61c43
Autor:
Jessica N. McCaffery, Balwan Singh, Douglas Nace, Alberto Moreno, Venkatachalam Udhayakumar, Eric Rogier
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-14 (2021)
Abstract Background As malaria incidence and transmission in a region decreases, it becomes increasingly difficult to identify areas of active transmission. Improved methods for identifying and monitoring foci of active malaria transmission are neede
Externí odkaz:
https://doaj.org/article/822cef6abd674fbba059e9f4ea253c1d
Autor:
Jessica N. McCaffery, Balwan Singh, Douglas Nace, Ashenafi Assefa, Jimee Hwang, Mateusz Plucinski, Nidia Calvo, Alberto Moreno, Venkatachalam Udhayakumar, Eric Rogier
Publikováno v:
PLoS ONE, Vol 17, Iss 5 (2022)
Background In low-transmission settings, accurate estimates of malaria transmission are needed to inform elimination targets. Detection of antimalarial antibodies provides exposure history, but previous studies have mainly relied on species-specific
Externí odkaz:
https://doaj.org/article/cc87cba407c3426a9483c4bc687c473e
Autor:
Dragan Ljolje, Pedro Rafael Dimbu, Julia Kelley, Ira Goldman, Douglas Nace, Aleixo Macaia, Eric S. Halsey, Pascal Ringwald, Filomeno Fortes, Venkatachalam Udhayakumar, Eldin Talundzic, Naomi W. Lucchi, Mateusz M. Plucinski
Publikováno v:
Malaria Journal, Vol 17, Iss 1, Pp 1-7 (2018)
Abstract Background Artemisinin-based combination therapy is the first-line anti-malarial treatment for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of polymorphisms in the pfk13 gene, associated with artemisinin r
Externí odkaz:
https://doaj.org/article/1d99150bdef440508b1d5b3d26a2113b
Autor:
Leah F. Moriarty, Venkatachalam Udhayakumar, Naomi W. Lucchi, Lansana Sangaré, Jules Mihigo, Halidou Sidibé, Celia Jane Woodfill, Ababacar Maïga, Douglas Nace, Eldin Talundzic, Lassina Doumbia, Erin Eckert, Youssouf Diarra, Dade Bouye Ben Haidara, O. Koita, Oumar Koné, Pharath Lim, Donald J. Krogstad, Hammadoun Aly Sango, Mouctar Diallo, Eric S. Halsey, Dragan Ljolje
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-13 (2021)
Malaria Journal
Malaria Journal
Background The current first-line treatments for uncomplicated malaria recommended by the National Malaria Control Programme in Mali are artemether–lumefantrine (AL) and artesunate–amodiaquine (ASAQ). From 2015 to 2016, an in vivo study was carri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f84d6d528d9318e7e81b1f8864bcfa49
https://doaj.org/article/ce50d1a8576342ba839a66fb31f52bfd
https://doaj.org/article/ce50d1a8576342ba839a66fb31f52bfd